Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Global Regulatory Systems01:28

Global Regulatory Systems

911
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
911
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

72
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
72
Drug Regulation01:25

Drug Regulation

3.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

478
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
478
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

659
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
659
Drug Products: Biologics, Biosimilars and Interchangeables01:28

Drug Products: Biologics, Biosimilars and Interchangeables

353
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
353

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Utilization of Clinical Evaluation Reports in Japan's Medical Device Approvals: Insights from Review Data on Approved Devices.

Therapeutic innovation & regulatory science·2026
Same author

Bone-targeting β-cyclodextrin phosphate has anti-resorptive activity and thereby prevents osteoporosis.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Facts and Issues of Submitting Applications (Public Knowledge-Based Applications) for Unapproved and Off-label Drugs With High Medical Needs in Japan.

Current therapeutic research, clinical and experimental·2026
Same author

Evaluation of computer-aided detection for gastric cancer using white-light and linked-color imaging: a pilot study.

iGIE : innovation, investigation and insights·2026
Same author

Inhibition of Cholesterol Transport from Lysosomes by Itraconazole Repolarizes Tumor-associated Macrophages to Anti-tumor M1 type.

Anticancer research·2025
Same author

Functional landscape of mechanistic diversity in 27 claudin family members at tight junctions.

Science advances·2025

Related Experiment Video

Updated: Apr 6, 2026

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities
07:13

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities

Published on: October 27, 2023

1.8K

Multiregional medical device development: regulatory perspective.

Atsushi Tamura1, Hiromu Kutsumi

  • 1Pharmaceuticals and Medical Devices Agency, Kansai Branch, Knowledge Capital Tower C9, Grand Front Building, 3-1 Ofuka-cho, Kita-ku, Osaka, 530-0011, Japan, tamura-atsushi@pmda.go.jp.

Clinical Journal of Gastroenterology
|July 18, 2015
PubMed
Summary

Global medical device development faces regulatory hurdles. Initiatives like "Harmonization by Doing" between the US and Japan aim to streamline clinical trials and speed up device approval for patients worldwide.

More Related Videos

Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding
10:43

Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding

Published on: June 27, 2014

20.6K
Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
09:06

Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome

Published on: December 12, 2025

892

Related Experiment Videos

Last Updated: Apr 6, 2026

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities
07:13

Author Spotlight: An Efficient and Robust Software for Automated Fusion of Multiple Preclinical Imaging Modalities

Published on: October 27, 2023

1.8K
Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding
10:43

Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding

Published on: June 27, 2014

20.6K
Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome
09:06

Microbioreactor-Based Production of Anchorage-Dependent Mesenchymal Stromal Cells Primed for Acute Respiratory Distress Syndrome

Published on: December 12, 2025

892

Area of Science:

  • Medical Device Regulation
  • Global Health Policy
  • Regulatory Harmonization

Background:

  • Medical device development is complex due to varying international regulations.
  • Globalization and timely patient access to innovative devices necessitate regulatory convergence.
  • Existing regulatory frameworks present barriers to simultaneous worldwide medical device development.

Purpose of the Study:

  • To explore efforts in harmonizing medical device regulations globally.
  • To understand initiatives aimed at overcoming regulatory impediments in device approval.
  • To highlight the importance of international collaboration in medical device regulation.

Main Methods:

  • Review of historical and current international regulatory harmonization efforts.
  • Analysis of bilateral initiatives such as "Harmonization by Doing" (US-Japan).
  • Examination of the evolution from the Global Harmonization Task Force (GHTF) to the International Medical Device Regulators Forum (IMDRF).

Main Results:

  • "Harmonization by Doing" facilitates global clinical trials and addresses regulatory barriers.
  • The Global Harmonization Task Force (GHTF) was established to promote uniformity in national regulatory systems.
  • The International Medical Device Regulators Forum (IMDRF) has succeeded the GHTF since 2012.

Conclusions:

  • International collaboration is crucial for streamlining medical device approval processes.
  • Harmonization efforts aim to reduce regulatory disparities and accelerate global market access.
  • The transition from GHTF to IMDRF signifies ongoing efforts to adapt and improve global medical device regulatory oversight.